Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

Reslizumab

🥰Excellent
Catalog No. T12706Cas No. 241473-69-8
Alias Sch55700, DCP-835, DCP835, CEP-38072, CEP38072

Reslizumab (Sch 55700) is a humanized immunoglobulin G (IgG)4 κ monoclonal antibody that binds to human interleukin 5, thereby decreasing eosinophil production and survival.Reslizumab improves lung function, induces a decrease in eosinophil production and maturation, and may be used in the study of asthma.

Reslizumab

Reslizumab

🥰Excellent
Catalog No. T12706Alias Sch55700, DCP-835, DCP835, CEP-38072, CEP38072Cas No. 241473-69-8
Reslizumab (Sch 55700) is a humanized immunoglobulin G (IgG)4 κ monoclonal antibody that binds to human interleukin 5, thereby decreasing eosinophil production and survival.Reslizumab improves lung function, induces a decrease in eosinophil production and maturation, and may be used in the study of asthma.
Pack SizePriceAvailabilityQuantity
1 mg$662In Stock
5 mg$1,770In Stock
10 mg$2,380In Stock
25 mg$3,530In Stock
50 mg$4,780In Stock
Bulk & Custom
Add to Cart
Questions
View More
Select Batch
Concentration:6.02 mg/mL
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
Reslizumab (Sch 55700) is a humanized immunoglobulin G (IgG)4 κ monoclonal antibody that binds to human interleukin 5, thereby decreasing eosinophil production and survival.Reslizumab improves lung function, induces a decrease in eosinophil production and maturation, and may be used in the study of asthma.
Targets&IC50
IL-5 (human):20 pM (Kd), IL-5 (human):109 pM (KD), Ba/F3 cells:0.5 nM
In vitro
Reslizumab binds with high affinity to human IL-5 in Biacore surface plasmon resonance, KD = 109 pM and in kinetic exclusion assays, KD = 4.3 pM. [1]
Reslizumab displays high affinity binding to hIL-5 (Kd = 20 pmol/l), inhibits the binding of hIL-5 to Ba/F3 cells (IC50 = 0.5 nmol/l) and blocks IL-5 mediated proliferation of human erythroleukemic TF-1 cells. [2]
In vivo
Intraperitoneal or intramuscular injection of 0-10 mg/kg Reslizumab inhibited pulmonary eosinophilia in allergic mice in a dose-dependent manner. [2]
Intravenous injection of 30 mg/kg Reslizumab inhibited allergic bronchoconstriction but not histamine-induced bronchoconstriction in allergic guinea pigs. Intravenous injection of 0.1-1 mg/kg Reslizumab blocked pulmonary eosinophilia and neutrophilia induced by tracheal injection of hIL-5 in guinea pigs. [2]
Intravenous 0.3 mg/kg Reslizumab blocked antigen-challenge-induced pulmonary eosinophilia for up to 6 months in allergic rhesus monkeys. [2]
AliasSch55700, DCP-835, DCP835, CEP-38072, CEP38072
Chemical Properties
Cas No.241473-69-8
Relative Density.no data available
Storage & Solubility Information
Storagestore at low temperature | store at -20°C | Shipping with blue ice.

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Reslizumab | purchase Reslizumab | Reslizumab cost | order Reslizumab | Reslizumab chemical structure | Reslizumab in vivo | Reslizumab in vitro